中华眼底病杂志

中华眼底病杂志

20例首诊于眼科的特发性颅内压增高症

查看全文

关键词: 视乳头水肿; 视野; 神经系统疾病/诊断; 磁共振成像; 血管造影术,数字减影

引用本文: 王一玮, 汪宇涵, 马瑾, 钟勇, 杨宁. 20例首诊于眼科的特发性颅内压增高症. 中华眼底病杂志, 2017, 33(5): 530-531. doi: 10.3760/cma.j.issn.1005-1015.2017.05.021 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Julayanont P, Karukote A, Ruthirago D, et al. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects[J]. J Pain Res, 2016, 9: 87-99. doi: 10.2147/JPR.S60633.
2. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children[J]. Neurology, 2013, 81(13): 1159-1165. DOI: 10.1212/WNL.0b013e3182a55f17.
3. Unsold R. Ophthalmological symptoms of idiopathic intracranial hypertension: Importance for diagnosis and clinical course[J]. Ophthalmologe, 2015, 112(10): 808-813. doi: 10.1007/s00347-015-0137-0.
4. De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis[J]. Neurol Sci, 2010, 31 Suppl 1: S33-39. DOI: 10.1007/s10072-010-0271-z.
5. Wall M. The importance of visual field testing in idiopathic intracranial hypertension[J]. Continuum (Minneapolis, Minn), 2014, 20(4): 1067-1074. DOI: 10.1212/01.CON.0000453302.20110.29.
6. Ball AK, Clarke CE. Idiopathic intracranial hypertension[J]. The Lancet Neurol, 2006, 5(5): 433-442. DOI: 10.1016/S1474-4422(06)70442-2.
7. Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension[J]. Ann Indian Acad Neurol, 2011, 14(1): 19-22. DOI: 10.4103/0972-2327.78044.
8. Thurtell MJ, Bruce BB, Newman NJ, et al. An update on idiopathic intracranial hypertension[J]. Rev Neurol Dis, 2010, 7(2-3): 56-68.
9. 孙国英, 刘瑛, 高阳, 等. 特发性颅内压增高症[J]. 中华眼底病杂志, 2008, 24(2): 150-154.Sun GY, Liu Y, Gao Y, et al. Idiopathic intracranial hypertension[J]. Chin J Ocul Fundus Dis, 2008, 24(2): 150-154.
10. Vieira DS, Masruha MR, Goncalves AL, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine[J]. Cephalalgia, 2008, 28(6): 609-613. DOI: 10.1111/j.1468-2982.2008.01564.x.
11. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema[J]. Headache, 2009, 49(2): 185-193. DOI: 10.1111/j.1526-4610.2008.01324.x.
12. Thurtell MJ, Newman NJ, Biousse V. Visual loss without papilledema in idiopathic intracranial hypertension[J]. J Neuroophthalmol, 2010, 30(1): 96-98. DOI: 10.1097/WNO.0b013e3181c5d0bc.
13. Killer HE, Laeng HR, Flammer J, et al. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations[J]. Br J Ophthalmol, 2003, 87(6): 777-781. DOI: 10.1136/bjo.87.6.777.
14. Killer HE, Jaggi GP, Flammer J, et al. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve: is it always bidirectional?[J]. Brain, 2007, 130(Pt 2): 514-520. DOI: 10.1093/brain/awl324.
15. Wall M, Johnson CA, Cello KE, et al. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2016, 57(3): 805-812. DOI: 10.1167/iovs.15-18626.
16. Keltner JL, Johnson CA, Cello KE, et al. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2014, 55(5): 3200-3207. DOI: 10.1167/iovs.14-14243.